BioMarin Pharmaceutical (BMRN) Earnings Date, Estimates & Call Transcripts $58.55 +0.46 (+0.79%) Closing price 04:00 PM EasternExtended Trading$58.76 +0.21 (+0.35%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BioMarin Pharmaceutical Earnings Summary BioMarin Pharmaceutical released Q4 2024 earnings on February 19, 2025, reporting an EPS of $0.72, which topped analysts' consensus estimates of $0.54 by $0.18. Quarterly revenue was reported to be $747.31 million, above the consensus estimate of $711.05 million. With a trailing EPS of $2.69 and a P/E Ratio of 26.61, BioMarin Pharmaceutical's earnings are expected to grow 38.41% next year, from $3.15 to $4.36 per share. Upcoming Earnings DateAug. 4After Market ClosesEstimatedConsensus EPS (Feb. 19) $0.54 Actual EPS (Feb. 19) $0.72 Beat By $0.18 Actual Revenue (Feb. 19) $747.31MQ4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Slide Deck Press Release (8-K) Annual Report (10-K)SEC FilingBMRN Upcoming EarningsBioMarin Pharmaceutical's next earnings date is estimated for Monday, August 4, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get BioMarin Pharmaceutical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioMarin Pharmaceutical and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBMRN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BMRN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. BioMarin Pharmaceutical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20253$0.48$0.77$0.65Q2 20253$0.73$0.94$0.82Q3 20253$0.82$0.90$0.85Q4 20253$0.67$0.91$0.80 FY 2025 12 $2.70 $3.52 $3.12 Q1 20262$0.91$0.93$0.92Q2 20262$0.97$0.99$0.98Q3 20262$0.98$1.05$1.02Q4 20261$1.13$1.13$1.13 BioMarin Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/4/2025(Estimated)--------2/19/2025Q4 2024$0.54$0.72+$0.18$0.64$711.05M$747.31M10/29/2024Q3 2024$0.78$0.55 -$0.23$0.93$703.37M$746.00M8/5/2024Q2 2024$0.38$0.77+$0.39$0.99$660.51M$712.03M4/24/2024Q1 2024$0.37$0.49+$0.12$0.52$649.75M$648.83M2/22/2024Q4 2023$0.4450$0.49+$0.0450$0.41$639.53M$646.21M11/1/2023Q3 2023$0.28$0.26 -$0.02$0.31$603.51M$581.33M7/31/2023Q2 2023$0.24$0.34+$0.10$0.39$591.46M$595.28M BioMarin Pharmaceutical Earnings - Frequently Asked Questions When is BioMarin Pharmaceutical's earnings date? BioMarin Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 4th, 2025 based off last year's report dates. Learn more on BMRN's earnings history. What guidance has BioMarin Pharmaceutical issued on next quarter's earnings? BioMarin Pharmaceutical issued an update on its FY 2025 earnings guidance on Thursday, May, 1st. The company provided earnings per share (EPS) guidance of 4.200-4.400 for the period, compared to the consensus EPS estimate of 4.300. The company issued revenue guidance of $3.1 billion-$3.2 billion, compared to the consensus revenue estimate of $3.1 billion. Did BioMarin Pharmaceutical beat their earnings estimates last quarter? In the previous quarter, BioMarin Pharmaceutical (NASDAQ:BMRN) reported $0.72 earnings per share (EPS) to beat the analysts' consensus estimate of $0.54 by $0.18. Learn more on analysts' earnings estimate vs. BMRN's actual earnings. How can I listen to BioMarin Pharmaceutical's earnings conference call? The conference call for BioMarin Pharmaceutical's latest earnings report can be listened to online. Listen to Conference Call How can I read BioMarin Pharmaceutical's conference call transcript? The conference call transcript for BioMarin Pharmaceutical's latest earnings report can be read online. Read Transcript How can I view BioMarin Pharmaceutical's earnings report? BioMarin Pharmaceutical's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does BioMarin Pharmaceutical generate each year? BioMarin Pharmaceutical (NASDAQ:BMRN) has a recorded annual revenue of $2.95 billion. How much profit does BioMarin Pharmaceutical generate each year? BioMarin Pharmaceutical (NASDAQ:BMRN) has a recorded net income of $167.65 million. BMRN has generated $2.69 earnings per share over the last four quarters. What is BioMarin Pharmaceutical's price-to-earnings ratio? BioMarin Pharmaceutical (NASDAQ:BMRN) has a trailing price-to-earnings ratio of 26.58 and a forward price-to-earnings ratio of 18.56. The price/earnings-to-growth ratio is 0.61. What is BioMarin Pharmaceutical's EPS forecast for next year? BioMarin Pharmaceutical's earnings are expected to grow from $3.15 per share to $4.36 per share in the next year, which is a 38.41% increase. More Earnings Resources from MarketBeat Related Companies ALNY Earnings Date BIIB Earnings Date UTHR Earnings Date INCY Earnings Date NBIX Earnings Date EXEL Earnings Date EXAS Earnings Date HALO Earnings Date RGEN Earnings Date MDGL Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CrowdStrike Stock Slips: Analyst Downgrades Before Earnings Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsAdvance Auto Parts: Did Earnings Defuse Tariff Concerns?Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH StockAdvance Auto Parts Jumps on Surprise Earnings BeatAlibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, Upgrades This page (NASDAQ:BMRN) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
